Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Progressive Care Announces 2019 Annual Report Earnings Call and Business Update on March 31, 2020
7:00 AM ET 3/25/20 | GlobeNewswire
Progressive Care Announces 2019 Annual Report Earnings Call and Business Update on March 31, 2020
MIAMI, FL, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Tuesday, March 31st, 2020.
"We are proud of our achievements in the last quarter of 2019. We are eager to update our shareholders on our current business initiatives during the pandemic and beyond," says Shital Mars, CEO.
Interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 5:00 PM EST on Monday, March 30, 2020. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. The questions addressed will be based on the relevance to the shareholder base, and the question's appropriateness in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/tag/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available at https://progressivecareus.com.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo Rx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care Inc. Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida technology and health services organization that provides prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements: Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact: Armen Karapetyan,
Progressive Care Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
> Dow Jones Newswires
March 25, 2020 07:00 ET (11:00 GMT)
Battery operated, using the same swapping technology! Good deal, I would buy one!
Exclusive: Pot company Cronos receives SEC inquiry
Published: March 20, 2020 at 9:50 a.m. ET
By Max A. Cherney
The SEC’s Enforcement Division has asked Cronos to preserve records related to the bulk purchase of resin and wholesale sales, according to internal communications, as company investigates revenue-recognition practices
The Securities and Exchange Commission has sent an inquiry to Cronos Group Inc., one of the largest cannabis producers in Canada, requesting the company retain records related to how it recognizes certain revenue, according to internal Cronos communications reviewed by MarketWatch.
In an email sent to employees from a company lawyer on March 10, Cronos CRON, -0.681% CRON, -1.402% instructed staff to retain certain records pertaining to a “confidential and non-public inquiry by the Securities and Exchange Commission.” The SEC Division of Enforcement has requested that the company retain and preserve all records about revenue recognition related to bulk-resin purchases and wholesale sales of biomass or other products, according to the email and an attached document. Bulk resin is a type of cannabis concentrate, and biomass is marijuana from which companies typically extract oil for vape products or edibles.
Cronos and the SEC declined to comment.
Cronos — a Canadian licensed pot producer backed by a $1.8 billion investment from tobacco company Altria Group Inc. MO, -4.636% — said in an SEC filing on March 2 that it was conducting an internal review into its accounting practices surrounding purchases of marijuana extracts and wholesale revenue. Cronos disclosed Tuesday that as a result of its review it would have to reissue three quarters of financial statements for 2019, and will report C$2.5 million in reduced revenue for the first quarter and C$5.1 million for the third quarter. The company also disclosed that it would likely report “one or more” material weaknesses in its internal controls related to financial reporting.
See also: Cronos paid $300 million for a small CBD company, and CEO’s private-equity firm stands to collect $120 million of it
Cronos instructed staff not to discuss the inquiry and to take immediate steps to preserve records dating back to July 1, 2018, the document says. The document instructs Cronos employees to preserve records related to specific transactions, negotiations and other dealings with MediPharm Labs Corp. LABS, 11.321%, a Canadian extraction business; TerrAscend Corp. TER, +11.39%, which operates dispensaries in California and elsewhere; and Canadian licensed producers Heritage Cannabis Holdings Corp. CANN, 4.000% and 48North Cannabis Corp. NRTH, -4.54%, along with subsidiaries of the companies.
48North, Heritage Cannabis and MediPharm declined to comment. TerrAscend did not respond to a request for comment.
Altria paid $1.8 billion to acquire a 45% stake in Cronos in December 2018, along with warrants that, if exercised, would raise that stake to 55%. The deal gave the maker of Marlboro and other tobacco brands an exclusive partnership in the cannabis sector just months after Canada fully legalized weed. Altria did not respond to a request for comment.
Source: https://finance.yahoo.com/m/79c6bf08-55e7-3a38-aff9-a5b927cbb737/exclusive-pot-company-cronos.html
$RJDG NEWS: RJD Green Inc. Updates the Acquisition Discussions with Their Healthcare Services Targeted Company, and the 2020 Projected Revenue Value of the IOSoft White Label Agreement
7:56 AM ET 3/16/20 | Dow Jones
TULSA, OK / ACCESSWIRE / March 16, 2020 / RJD Green Inc. (OTC PINK:RJDG) CEO, Ron Brewer, announced today the IRG group had notified the IOSoft Division of RJD Green Inc. of their expected purchases in 2020 and 2021. Further Mr. Brewer stated the discussions with their targeted healthcare services acquisition have progressed.
Iconic Resources Group
IRG forwarded their projected expenditures with IOSoft from the White Label agreement of the Unified Payment System. Projected revenues for IOSoft in 2020 was stated at $350,000 to $700,000 with 2021 to be a minimum of a 100% increase.
IRG has harnessed the power of innovative solutions and technologies to assist their clients in identifying and selling prospects, and enhanced delivery of financial products and services distributed for the benefit of insurance carriers, brokerage agencies, IMOs, banks, and wealth advisors. www.iconicresourcegroup.com
Healthcare Sector IT Services Acquisition
Mr. Brewer stated RJD Green and its acquisition target have agreed upon general terms of purchase in the form of an MOU. As well, both companies and RJD Green's equity partners agreed to delay entering into the initial due diligence phase for forty-five days, allowing for a better picture of the current national economic and health issues.
IOSoft Inc.
IOSoft provides proprietary software for medical billing thru their Unified Payment System, Healthcare claims adjudication, automotive warranty payments, and electronic payments between healthcare Payers and Providers, along with custom payment software platforms for corporations, government & institutional organizations. Since formation, IOSOFT has been a third-party developer of software providing IT support for the platforms developed along with all "back office" services to include sales and marketing support.
The primary focus of IOSoft is in healthcare payment systems where IOSoft can provide unique payment technologies and services or software that can be integrated with legacy or existing systems of healthcare payers and providers such as, major health insurance carriers and third-party administrators. IOSoft provides targeted product offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies. www.iosoftinc.com.
About RJD Green, Inc.
The Company operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSoft Inc., a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies; and Silex Holdings Division, which is engaged in specialty construction and industrial manufacturing and fills a market niche between the Home Depots and local contractors. Silex offers installed granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and retail customer.
www.rjdgreen.com
Forward-looking Statement:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Company Contact:
RJD Green, Inc.
Ron Brewer, CEO
918.551.7883
ronb@rjdgreen.com
Company Publicist:
Douglass Baker
OTC PR Group
(561) 807-6350
corp@otcprgroup.com
SOURCE: RJD Green Inc.
View source version on accesswire.com:
https://www.accesswire.com/580879/RJD-Green-Inc-Updates-the-Acquisition-Discussions-with-Their-Healthcare-Services-Targeted-Company-and-the-2020-Projected-Revenue-Value-of-the-IOSoft-White-Label-Agreement
> Dow Jones Newswires
Progressive Care Inc. Introduces Comprehensive Website Redesign
8:00 AM ET 3/11/20 | GlobeNewswire
Progressive Care Inc. Introduces Comprehensive Website Redesign
MIAMI, March 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care" or the "Company"), a personalized healthcare services and technology company, is proud to announce the launch of its newly redesigned website.
Technology development has been an integral goal at Progressive Care, offering the best user experience to our shareholders and customers has been paramount for the first quarter of 2020. The new website is now available to the public and will feature seven tabs, to include: company overview, news, events & presentations, financials, governance, stock, and investor resources. All crucial information related to Progressive Care Inc. (OTCQB: RXMD), including the latest press releases, company events, quarterly results, and real-time stock quotes are now available at http://progressivecareus.com.
"We wanted to offer a platform that enhances transparency and gathers all relevant information related to the company. Our goal is to have more seamless engagement with the public and we felt that updating our digital assets is essential for success. Our executive team understands how connected healthcare and technology is and are taking full advantage of upcoming trends." -Ms. Shital Mars, CEO of Progressive Care Inc.
During the preliminary first quarter, the Company has focused on technology and continues to stay abreast on trends. Progressive Care is building a team to continue upgrading its online presence and developing a new state-of-the-art platform that will connect the operations with not only its patients, but prescribers, staff, and anyone else who is involved in patient care.
"We're moving at a fast pace and are excited about the introduction of our proprietary technology this year. We believe that the future of healthcare belongs to companies that understand how on-demand applications are changing the way healthcare will be delivered. Progressive Care Inc. will be at the forefront of this technological evolution and will continue to build shareholder value."
Full investor's deck presentation is now available to download from the website. For more information about Progressive Care, please visit the Company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate, " "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcorx.com
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
> Dow Jones Newswires
March 11, 2020 08:00 ET (12:00 GMT)
$12 for me
Happy Friday morning news!
SugarMade is happy to announce that #Budcars is adding delivery to Napa Valley and Sonoma wine country. Have a great weekend! Enjoy the short clip.
#cbdhealth #cannabis $SGMD #CannabisMedicinal #edibles #delivery
SugarMade is happy to announce that #Budcars is adding delivery to Napa Valley and Sonoma wine country. Have a great weekend! Enjoy the short clip. #cbdhealth #cannabis $SGMD #CannabisMedicinal #edibles #delivery pic.twitter.com/vVogp0Xbil
— Sugarmade Inc (OTC:SGMD) (@Sugarmade1) March 6, 2020
Will Aurora Cannabis (ACB) Have to Give Up Control to Reverse Its Fortunes?
One of the things that has attracted me to Aurora Cannabis (ACB) for some time has been its decision to forego giving up control of the company as Canopy Growth (CGC) has done, which eventually resulted in Constellation Brands taking control of Canopy, while changing its business model.
With Aurora under pressure because of the problems associated with the Canadian cannabis market, especially the snails pace of awarding licensing and opening retail outlets, resulting in too much supply because Aurora and others had based production capacity built-out, to a major degree, on hundreds more stores being opened by now.
In this article we'll look at whether or not Aurora should, or will be forced to, give up control of the company in order to support long-term operations and growth, or even if it will be able to attract a suitor now that the Canadian cannabis market has temporarily collapsed.
Understanding the Canadian problem
It's obvious as to the basic failure of the Canadian governments in regard to the licensing process and the serious lack of retail cannabis stores to sell product in. What isn't understood as much are the various elements of the business and market and how they've been impacted by this.
For example, the black market continues to flourish and defend its lower prices because in the major Ontario and Quebec markets they have almost no competition from the legal cannabis market. Because companies have limitations associated with the inability to scale because of so few stores, they can't compete on price with illegal producers and sellers.
Another factor is it limits the potential to attract many new customers that may want to give cannabis a try for the first time. It also undermines the potential of derivatives because of the lack of retail outlets.
Can or will Aurora seek out an investment partner
Watching the terrible impact of Canopy Growth's under performance on the earnings of Constellation Brands, it's going to be difficult for Aurora to attract a large suitor if that's what it decides to do.
On the other hand, the plummet in the valuation of the company makes it much less expensive to take a significant position in, if a company wants to enter the cannabis sector with one of the largest producers in the world as its partner.
I think a major problem here is that those that have been impressed with Aurora, have been so because of its independence and willingness to take risks. If it changes direction and gets a cash infusion in exchange for basically losing control of the company, it will no longer be as attractive over the long haul, once the cannabis market reverses direction.
At the same time, it will need more capital going forward, so it will have to decide what direction it wants to take to cover its expenses as it and the cannabis market go through growing pains.
As mentioned earlier, the company isn't near as attractive as it was about a year ago, and it's questionable whether or not it can attract a company that wants to invest in it.
For that reason, making a deal with a distribution partner or partners may be a better route to take as long as it can raise additional capital.
Conclusion
Personally, I think Aurora Cannabis can continue to go it alone if it chooses to, although it will require it to find ways to improve its balance sheet.
The other challenge is the lack of progress in Canada has created an issue concerning what I call demand discovery, by which I mean there is no way of knowing the size of the legal cannabis market demand in Canada until hundreds of more cannabis stores and dispensaries are operational; that makes it hard to plan for future production capacity management.
As with all the cannabis producers located in Canada, Aurora Cannabis has an important piece of the business puzzle outside of its control, and based upon past performance of the various Canadian governments, this isn't inspirational for near-term prospects for the company.
Aurora still has among the best cost per gram and has been able to be among the top five recreational sellers in Canada based upon price. It also has a strong presence in international markets that it has just started to tap the potential growth in.
The key will be securing more operating capital in order for the market to work out the challenges the company now faces. If it manages to do that, it's still my favorite for long-term performance in the sector.
To find good ideas for cannabis stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.
Source: https://finance.yahoo.com/news/aurora-cannabis-acb-control-reverse-230630338.html
Sugarmade Announces Budcars Delivery Volume Growth Now Supports $15M+ 2020 Revenue Target
8:30 AM ET 3/4/20 | GlobeNewswire
Sugarmade Announces Budcars Delivery Volume Growth Now Supports $15M+ 2020 Revenue Target
NEW YORK, March 04, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Sugarmade, Inc. (OTCQB:SGMD) ("Sugarmade", "SGMD", or the "Company") is excited to announce a dramatic 300 percent sequential monthly jump in delivery volume in BudCars Cannabis Delivery Service ("Budcars") in February. The rise in volume follows the Company's negotiated agreement toward a controlling stake in Budcars and its investment in expanding the leading delivery service's operations and reach in Northern California. Management now projects a Budcars top-line run-rate capable of surpassing $15 million in sales in 2020, provided recent data on growth in daily orders is reliable and indicative of the impact of the Company's recent measures over coming months.
The Company has negotiated a 40 percent stake in Budcars with a provisional option to assume a controlling ownership position through the acquisition of an additional 30 percent stake.
"Some of our shareholders have suggested that our vision for a massively expanded and vertically integrated Budcars might be explained to the world as the 'Uber Eats of the cannabis market.' But we believe that's actually a dramatic underestimation of where Budcars is headed," remarked Jimmy Chan, CEO of Sugarmade. "This is far more promising from a bottom-line perspective, given that we aren't simply delivering someone else's product. The retailer gets the juicy 20 percent net margin in this business. We are positioning ourselves as a 'Cannabis concierge service' focusing on a truly unique cannabis experience."
Management notes that recent regulatory changes in the California legal cannabis market point to a dramatic turnaround in progress in 2020 as competition from unregulated suppliers is suppressed, widening margins for licensed producers and distributors. The Company cites this transition as key in driving its strategic investment in Budcars, which was predicated on a verticalization premise that positions the Company as a dominant cannabis supplier, driving market share gains through the value-add of its efficient delivery service without sacrificing the core margin opportunity coming into place as a legal cannabis supplier.
Since Sugarmade management became heavily involved in the day-to-day operational and strategic foundation of Budcars in early February, following its initial investment and investor agreement, the Company has witnessed a dramatic expansion in overall delivery volume with February deliveries topping January volume by more than 300 percent. The Company believes this jump has been driven by an improving overall cannabis market in California, an infusion of operational talent and resources, and an expanded geographic service area. In order to meet demand, Budcars is increasing its road fleet, inventory, staffing, and will be positioning strategic billboard campaigns along major freeways in the service region.
Chan continued, "Our move to take a controlling interest in Budcars is about capturing the healthy margins set to define the California legal cannabis market in 2020 and beyond, and about nailing down a competitive advantage in market share afforded by a well-organized delivery service, which is an enormous customer hot-button in the legal cannabis marketplace. So far, we are seeing powerful performance-based feedback from the marketplace that we're on the right track."
About Sugarmade, Inc.
Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. Our Brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. For more information please reference www.Sugarmade.com.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others, such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements.
Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Corporate Contact:
Jimmy Chan
+1-(888)-982-1628
info@Sugarmade.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
> Dow Jones Newswires
March 04, 2020 08:30 ET (13:30 GMT)
The Best Movie Subscription Services Come Pretty Close to the Magic of MoviePass
Daniel Varghese
GQMarch 4, 2020, 4:28 PM EST
The Best Movie Subscription Services Come Pretty Close to the Magic of MoviePass
The Best Movie Subscription Services Come Pretty Close to the Magic of MoviePass
MoviePass might have been one of the worst run companies in the world, but the idea of movie subscription services really stuck for people like me: people that have Netflix and Hulu and Disney+ subscriptions but would vastly prefer to watch Movies on Screens if they weren't quite so expensive. And now, all the theaters that were once forced to work with the nincompoops running MoviePass have started their own movie subscription services. None of them are even remotely as cheap as MoviePass, nor do any of them give you the flexibility to watch movies at any theater you want. These movie subscription services basically make you (and by extension they friends and family members you typically go to the movies with) exclusive customers of one movie theater chain. But, that's honestly okay. If you're the kind of person who would ideally go to several movies a month, any subscription you choose would save you money—especially if you sneak in snacks. Here are all the best movie subscription services that have risen from the ashes of MoviePass.
AMC Stubs A-List: The Best Unlimited Movie Subscription Service
Why it's good: Largely unrestricted access to any showing at a ubiquitous theater chain with no extra convenience fees. The closest thing to a MoviePass successor we'll likely ever see.
What you get: AMC Stubs A-List gets you three free movies a week at any AMC theater. While other services only allow you to reserve seats a week or a few days in advance, A-List will let you reserve seats for any showing that is available online, even if that showing isn't for weeks. No longer will you be barred from competing against the plebs without a subscription for the primo seat for [insert new MCU movie here]. AMC A-List members get access to a special lane in the concessions line at the theaters, as well as 10% back on food and drink purchases. If that happens to be popcorn and fountain drinks, you get a free size upgrade. You also get a free large popcorn and fountain drink on your birthday. But maybe the best thing about it is that you're able to watch movies in any format (Dolby Cinema, IMAX, or 3D) without paying anything additional.
What you pay: Pricing for AMC Stubs A-List varies depending on where you live and whether you plan to see movies in other states. If you're based in New York, where you must choose the plan that gives you access to all states, it is $23.95 a month. If you only plan to see movies in Kentucky, you can become an A-List member for $19.95. Either way, you don't have to pay any convenience fees when you're reserving your tickets.
Where you can get it: There's basically an AMC theater everywhere that isn't Brooklyn. You can see the full list here.
Alamo Drafhouse Season Pass: The Upgraded Unlimited Movie Subscription Service (for Cities That Actually Have a Drafthouse Location)
Why it's good: Alamo Drafthouse theaters offer a better theater-going experience (as long as you don't mind servers nimbly walking around doing a show) than any others right now. The subscription isn't cheap and does include additional fees, but if you go to two showings a month, it's worth it.
What you get: For its price, Alamo Season Pass is a pretty restrictive unlimited movie subscription service service. You get access to one regularly priced screening per day, though you can reserve it up to seven days in advance. You don't get any special discounts on the theater's excellent food or drinks, but your tickets still rack up points with the company's rewards system that can translate to free food and drinks.
What you pay: The season pass is not cheap. If you are so lucky as to live in New Braunfels, TX, you can get the Big Boat plan for $15 a month, though you'll have to pay for tickets at any other theaters. If your main theater is in a different city (that isn't New York, Los Angeles, or San Francisco), you can get the Bigger Boat plan for $20 a month, but you'll have to pay extra for screenings in those two larger size locations. If you do live in New York, LA, or San Francisco, the Season Pass will cost you $30. And at any plan, you'll still have to pay the same convenience fees you'd pay if you weren't a season pass member, which is annoying. But if you plan to watch two movies a month at any of the plans, they still end up saving you a little money.
Where you can get it: The Season Pass is available in all the cities with a Drafthouse location. See the full list of locations here.
Cinemark Movie Club: The Best Movie Subscription Service for Seeing One Movie a Month
Why it's good: Just because you like movies, doesn't mean you need unlimited movies. If you only see one movie a month, or don't want to be locked in to seeing every movie you want to see at one theater chain, the Cinemark Movie Club will automatically save you money every month.
What you get: The Cinemark Movie Club isn't an unlimited movie subscription service, but that might actually be what you want. Being a member of the club gets you one redeemable ticket credit per month, which you can use for any standard 2D screening. You can use those credits to reserve seats in advance or pay an upcharge to see a movie in a premium format. Any credits you don't use roll over to the next month. Being a member also gets you 20% off concessions and special pricing on a companion ticket.
What You Pay: The service costs $10 a month for the service. There are no convenience fees charged.
Where you can get it: You can see the full list of Cinemark theaters here.
Regal Unlimited Movie Subscription Services: A More Restrictive Alternative
Why it's good: It offers you most of the features of a movie subscription service that you probably care about, but it's a bit more restrictive.
What you get: The Regal Unlimited movie subscription service is fairly straightforward. You can use the service to see as many standard showings of movies you want, you just can't see the same movie on the same day in the same format. You are able to use your subscription to access showings in the more premium formats, but you'll have to pay a surcharge. Your membership also gets you a 10% discount on food and non-alcoholic drink purchases and a free large popcorn and soft drink on your birthday.
What you pay: Depending on where you live, you might be forced into the top tier Regal Unlimited All-Access plan, which is $23.50 a month. At its base that's cheaper than AMC Stubs A-List, but you have to pay a $0.50 convenience fee to reserve any ticket through the system. That means that watching one movie makes it more expensive. The Regal Unlimited Plus subscription includes fewer theaters for $21 a month. And the base Regal Unlimited plan is $18 a month. Regardless of the plan you're on, you'll have to pay that convenience fee anytime you book a ticket. And when you sign up, you're locked in for an entire year.
Where you can get it: You can see the complete list of Regal theaters, which includes information about which plans work at which theaters, here.
Originally Appeared on GQ
Source: https://www.yahoo.com/lifestyle/best-movie-subscription-services-come-212819928.html
(NPHC) Nutra Pharma Provides Updates on Marketing and Distribution
8:31 AM ET 3/3/20 | Dow Jones
Coral Springs, Florida--(Newsfile Corp. - March 3, 2020) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin(R) and Pet Pain-Away(TM) in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, provided updates today on their progress in the marketing and distribution of Nyloxin, Pet Pain-Away and Equine Pain-Away.
"We have been very busy in laying the groundwork for increasing brand awareness, online visibility and product messaging in preparation for our rollout into retail stores later this year," commented Rik J Deitsch, CEO of Nutra Pharma Corporation. "This began with the relaunch of our Nyloxin website last year. We also launched our newest product, Equine Pain-Away, in November," he continued. "We've been working with professional marketing teams that have built increased online awareness and have greatly improved our presence on Amazon. These pages now include testimonials, videos and product comparisons; which have resulted in month over month sales growth. All of this is in preparation for our rollout into retail stores over the summer. We have already begun the on-boarding process to launch Nyloxin Topical Gel into grocery with the expectation to be in at least 5000 locations by the end of this year," he concluded.
The company now markets Nyloxin on www.Nyloxin.com as well as their Amazon marketplace. Pet Pain-Away is being marketed through www.Pet-Pain-Away.com as well as www.PetPainWay.co. Equine Pain-Away has seen initial sales growth and is being marketed through www.EquinePainAway.co.
"As we've outlined previously, with the nation focused on the treatment of chronic pain and the reduction of opiate use, we believe that our opioid-free solutions, including Nyloxin and Pet Pain-Away, will be the products of choice for chronic pain with the right marketing and consumer education," commented Nina Goldstein, Director of Marketing. "We've already placed these products in small chain pharmacies, physician offices and medical clinics. With the expansion into retail later this year, we believe that the Company will see these products becoming staples for the treatment of chronic pain and inflammation," she concluded.
Nyloxin(R) is a safe, non-narcotic, and non-addictive Homeopathic pain reliever clinically proven to treat moderate to severe chronic pain while not impairing cognitive function. Nyloxin(R) offers several benefits as pain relievers and anti-inflammatory agents. With increasing concern about consumers using opioid and acetaminophen-based pain relievers, Nyloxin(R) offers an opioid-free alternative that does not rely on opiates or non-steroidal anti-inflammatory drugs, otherwise known as NSAIDs, for their pain relieving effects. Nyloxin(R) has a well-defined safety profile. Since the early 1930s, the active pharmaceutical ingredient (API), Asian cobra venom, has been studied in more than 46 human clinical studies.
Pet Pain-Away(TM) is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever. The product is primarily aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in dogs and cats. Specialized proteins in Pet Pain-Away(TM) block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin(R) and Pet Pain-Away(TM). For additional information about Nutra Pharma, visit:
http://www.NutraPharma.com or
http://www.nyloxin.com
http://www.petpainaway.com
SEC Disclaimer
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The marketing update for the Company's pain relievers should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Contact:
Nutra Pharma Corp.
Nina Goldstein
877-895-5647
IR@nutrapharma.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53049
> Dow Jones Newswires
March 03, 2020 08:31 ET (13:31 GMT)
LEST RUN TODAY $NPHC
Somebody knows something!
Progressive Care Posts Record January Performance, Will Begin Major Exchange Uplisting Process in April
8:00 AM ET 2/21/20 | GlobeNewswire
Progressive Care Posts Record January Performance, Will Begin Major Exchange Uplisting Process in April
MIAMI, FL, Feb. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care" or the "Company"), a personalized healthcare services and technology company, is excited to announce operational performance data for January 2020, which represented a record-breaking monthly performance for Progressive Care:
-- Consolidated monthly gross sales across all locations totaled $3.05
million, representing year-over-year growth of 60.5% compared to January
2019,
-- Prescriptions filled during the month came in at 43,933, representing
year-over-year growth of 42% compared to January 2019,
-- Approximately $700k in claim submissions for not-for-profit entities*
-- Top performance scores achieved with major PBMs,
-- All stores placed in the top 20% in the nation for 2019 resulting in an
additional $600k in fees returned to the company,
-- Total performance payout is about $800k and will be reflected in 2019
full-year financial results,
-- Will file with SEC for fully reporting status and begin the process of
uplisting to NYSE or Nasdaq in April.
*All claims processed for not-for-profit entities are conducted on an agency basis. Thus the gross value of the submissions are excluded from gross sales. Transaction fees due to the company as a result of these claims are included in gross sales calculations.
S. Parikh Mars, CEO of Progressive Care, remarked, "In terms of growth and efficiency, January was a strong continuation of the core trends that defined our record-breaking performance in the second half of 2019. We continue to see organic growth at all locations, and our evolution toward widening gross margins through incremental gains in efficiency in all phases continues to drive our results. It was another great month."
The Company will file fully-audited fiscal 2019 financial results on or before March 31, 2020. The Company will then file a Form S-1 registration statement with the US Securities and Exchange Commission to obtain fully reporting status, and then move to uplist shares onto a major US exchange.
Management continues to value opportunities to present Progressive Care's larger vision in front of an upcoming move to a major US exchange. To that end, the Company's CEO, Mars, presented at NobleCon16 - Noble Capital Markets' Sixteenth Annual Investor Conference, on February 18 in Hollywood, Florida. You can download a copy of the presentation using the following link: https://progressivecareus.com/investor-relations/
"Our time at the conference was very productive," continued Mars. "We are extremely optimistic that any obstacles in front of us can be overcome as we strive to bring our big ideas to fruition and complete our evolution from a pharmacy model to a more scalable, technology-driven comprehensive health services model."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate, " "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Attachment
-- Progressive Care, Inc.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Caitlin Franscell, CMW Media
caitlin@cmwmedia.com
www.cmwmedia.com
> Dow Jones Newswires
February 21, 2020 08:00 ET (13:00 GMT)
The favorite lube is sand...
RJD Green Inc.s Specialty Contracting Division Silex Holdings Announced Additional Commercial Contracts Sold in 2020
8:30 AM ET 2/18/20 | GlobeNewswire
RJD Green Inc.'s Specialty Contracting Division Silex Holdings Announced Additional Commercial Contracts Sold in 2020
TULSA, OK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- RJD Green (OTCPK: RJDG), Silex Holdings announced three commercial projects were sold in January 2020.
RJD Green Inc. announced the awarding of three commercial projects to Silex Holdings specialty construction division. The contracts total $238,351, making a positive start on increased commercial division revenues in 2020.
Silex Holdings is continuing its commercial business growth as a primary focus in 2020.
Ron Brewer, CEO of RJD Green Inc., states, "Silex continues the progression in solidifying long-term relationships with valued clients in the construction industry by providing custom quality product with fast turnaround times on our clients' orders. With an increased commercial business development program implemented, Silex will cautiously continue the broadening of our client base enhancing the assurance of a stable and growing revenue stream."
About RJD Green, Inc.
The Company operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which holds interest in IoSoft Inc, a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers: Earthlinc Environmental Services Division, which provides green environmental services and technologies; Silex Holdings Division, which is engaged in specialty construction and industrial manufacturing and fills a market niche between the Home Depots and local contractors. Silex offers installed granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and retail customer. Visit http://www.rjdgreen.com
For additional information, contact Ron Brewer, CEO at ronb@rjdgreen.com, or at (918) 551-7883, or Douglass Baker, OTC PR Group at corp@otcprgroup.com or at (561) 807-6350.
Forward-looking Statement:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
> Dow Jones Newswires
February 18, 2020 08:30 ET (13:30 GMT)
I wouldn't say it's a shame. I would say that marijuana stocks are testing the waters, since "legalization" between quotes. The "war on drugs" between quotes still going on. One way or another.
Truth being said, shame in the government.
Aurora Cannabis Inc Cut to Neutral From Buy by PI Financial
11:57 AM ET 2/10/20 | Dow Jones
Ratings actions from Baystreet: http://www.baystreet.ca
> Dow Jones Newswires
February 10, 2020 11:57 ET (16:57 GMT)
I don't get why this company hasn't been seen yet:
https://www.yahoo.com/finance/news/illegal-tender-podcast-the-united-states-of-opioids-011600893.html
In fact I know, but the way it's going it's pretty sad for the United States of America.
Fentanyl, 50 times more powerful than heroin...
TESLA $1,000
Progressive Care Provides Support for Concerns Related to the Spread of Wuhan Coronavirus (2019-nCoV)
8:00 AM ET 1/30/20 | GlobeNewswire
Progressive Care Provides Support for Concerns Related to the Spread of Wuhan Coronavirus (2019-nCoV)
MIAMI, FL, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care" or the "Company"), a personalized healthcare services and technology company, in an effort to provide support and resources for those concerned about the risks associated with the emerging threat posed by the spread of Wuhan Coronavirus (2019-nCoV), is pleased to provide critical educational and informational support services at this important stage in the progression of the disease.
What to Know: According to the World Health Organization ("WHO"), Coronaviruses (CoV) are "a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV)."
On December 31, 2019, the WHO became aware of new strain -- a "novel coronavirus (nCoV)" -- not previously identified in humans that first appeared in the form of pneumonia in Wuhan City, Hubei Province of China. It appears as though this marks the emergence of a new infectious disease borne of a non-human-to-human virus in this region that mutated into a state allowing for human-to-human infectious transmission.
This disease has spread rapidly. Many questions still remain, including whether or not the disease is fully contagious in the pre-symptomatic incubation period. Chinese authorities and authorities in many countries are already taking rapid action to slow the spread of the disease, and biomedical facilities around the world are working hard to create a viable vaccine, with some early-stage candidate compositions already beginning animal testing.
Worldwide there are now more than 6,000 cases and 132 deaths, according to the European Centre for Disease Prevention and Control. There have been no reported deaths outside of China and all deaths have been in patients who were elderly or otherwise unwell. In the U.S., the CDC is reporting five confirmed cases from these states: Washington, Illinois, California, and Arizona, all of whom had recently visited Wuhan. According to the CDC, there is no evidence that 2019-nCoV has spread from human to human in the US, nor is there evidence that imported Chinese goods are affected. The mortality rate for those infected by 2019-nCoV is not yet fully understood but appears to be relatively low in the scale of prior serious infectious disease epidemics, with many patients recovering over a period of days back to full health.
What to Do: The WHO has a list of suggested guidelines for behavioral prevention of infection with Wuhan Coronavirus:
-- Frequently clean hands by using alcohol-based hand rub or soap and water;
-- When coughing and sneezing, cover mouth and nose with flexed elbow or
tissue -- throw the tissue away immediately and wash hands;
-- Avoid close contact with anyone who has a fever and cough;
-- If you have fever, cough and difficulty breathing, seek medical care
early and share previous travel history with your health care provider;
-- When visiting live markets in areas currently experiencing cases of novel
coronavirus, avoid direct unprotected contact with live animals and
surfaces in contact with animals;
-- The consumption of raw or undercooked animal products should be avoided.
Raw meat, milk or animal organs should be handled with care, to avoid
cross-contamination with uncooked foods, as per good food safety
practices.
According to WebMD, symptoms include fever, coughing, and shortness of breath. They may appear 2 to 14 days after you're exposed to the virus. The flu and its symptoms are common and it is recommended to be treated with Tamiflu(R) and more recently Relenza Diskhaler(R). The Coronavirus is very similar to the flu and has most of the same symptoms aside from a history of travel exposure. Pamela Roberts, PharmD, Director of Pharmacy stated "Treatment would be similar for both viruses. Symptomatic care would consist of lots of fluids, rest, and OTC pain relievers as needed."
"It is important to stay calm and follow common flu/disease prevention protocols. Wash hands thoroughly, avoid direct contact with anyone showing flu-like symptoms, and seek early diagnosis and treatment when symptoms present themselves," said S. Parikh Mars, CEO.
For More Help: If you or someone you know has further questions or concerns about the risks posed by Wuhan Coronavirus, including how to prevent infection or how to respond to potential associated symptoms, please contact PharmCo, and a team member with expertise will be happy to assist you.
Our Toll-Free Number is 831-901-9111, or email us at Info@PharmcoRx.com
The CDC has provided the following link for current developments regarding 2019-nCoV: https://www.cdc.gov/coronavirus/index.html.
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate, " "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Caitlin Franscell, CMW Media
caitlin@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com
> Dow Jones Newswires
January 30, 2020 08:00 ET (13:00 GMT)
Sugarmade CEO: The On-Demand Economy is Headed to the Cannabis Sector - Its Where We Want to Play
8:30 AM ET 1/29/20 | GlobeNewswire
Sugarmade CEO: The On-Demand Economy is Headed to the Cannabis Sector - It's Where We Want to Play
NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Sugarmade, Inc. (OTCQB:SGMD) ("Sugarmade", "SGMD", or the "Company"), today announces a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. Sugarmade will be making several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and via new relationships with proven sector business operators.
The on-demand economy is shifting power from business toward consumers, who are increasingly demanding goods and services on their own terms with a growing expectation for near-term gratification. No longer are consumers reliant on the traditional supply chain model, but instead are able to order numerous products and services with delivery in a matter of hours. This desire for instant access to products and services is now reaching the regulated cannabis market sector and many expect the sector to never be the same. In a radical shift in its business model, Sugarmade will be part of the on-demand revolution sweeping the regulated cannabis industry.
"Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is our goal to ensure Sugarmade is an important component of these trends. We see the acceleration of on-demand services within the cannabis sector and we believe it is the most lucrative area for us to pursue," commented Jimmy Chan, CEO of Sugarmade. "We have radically changed our business model via internally developed initiatives and through upcoming relationships with established sector participants. Our investors should stay tuned for our new business model to develop over the coming weeks."
For the past year, Sugarmade has observed numerous changes in the cannabis industry, many of which have been painful for sector participants. Several subsectors have collapsed and the Company believes several others are headed into troubled waters. Sugarmade plans to capitalize on its observations and on its staff's extensive industry contacts to evolve the corporate business operation to not only survive the current industry turmoil but to also thrive. Targeting the on-demand trend in the regulated cannabis sector will be a major component of the Company's future.
Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The Company has made agreements with several market participants, which will be announced over the coming weeks. The Company views these opportunities as very scalable and capable of producing strong revenue growth for the Company.
Mr. Chan continued, "The opportunities we have negotiated are with established operations, which will allow us to begin revenue generation over the short term. Additionally, we have several internally developed programs that will add a new and unique spin to the existing cannabis distribution model. We plan to inform our investors of these actions over the coming weeks as we solidify these opportunities."
About Sugarmade, Inc.
Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.sugarmade.com.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others. such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Corporate Contact:
Jimmy Chan
+1-(888)-982-1628
info@Sugarmade.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
> Dow Jones Newswires
January 29, 2020 08:30 ET (13:30 GMT)
Progressive Care Inc. Releases Shareholder Letter from CEO
8:00 AM ET 1/23/20 | GlobeNewswire
Progressive Care Inc. Releases Shareholder Letter from CEO
MIAMI, FL, Jan. 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care" or the "Company"), a personalized healthcare services and technology company, issues the following Letter to Shareholders from the CEO:
Dear Valued Shareholder,
Allow me to begin by expressing our heartfelt gratitude to all of our committed shareholders for your faith and patience as we move toward what we sincerely believe will be the most exciting and gratifying period in the Company's history. None of this would be possible without you.
Before we talk about where we are headed next, we must take a moment to appreciate how far we have come.
2019 was a formative year for Progressive Care as a company, both in terms of our culture and our character. Presented with unforeseeable exogenous obstacles early in the year, could we muster the will and determination to adapt and create success despite that adversity?
I am extremely proud to proclaim here today -- as we kick off a very promising new year -- that our team successfully rose to the challenges we faced early last year, and we enter 2020 stronger than we have ever been, more efficient than we have ever been, and equipped with a more scalable model than we have ever had in place before in our history.
A year ago, we closed 2018 on a very strong note, having just secured our flagship building in Hallandale as well as funding of $1 million earmarked for an ambitious tech-centric 2019 vision -- we are true believers in the potential for new and innovative technology solutions to deliver personalized patient-centered care, and we had formulated a plan to deliver on that promise in 2019.
However, early last year, we were hit with deep cuts to reimbursements and monumental hikes in fees in our PBM relationships. Those exogenous shocks refocused our team on growth and adaptation. The infusion of capital served as the company's lifeblood during this difficult but enormously valuable period. We strategized and found multiple ways to become leaner and to effectively brace ourselves for the impact of a more exploitative PBM landscape. But we also recognized that it would take more than just good defense to successfully navigate the transition, so we ured our focus to growth and innovation.
In the first half of the year, we saw extended growth in prescription counts and revenues. With a full year of PharmCo Rx Palm Beach to look forward to, we optimized our branding, workflow, and sales methods to deliver organic growth in the South Florida area.
We also found a tremendous M&A opportunity in Family Physicians Rx ("FPRx" or "FSRx"). With 2 locations, prescription counts that exceeded 15,000 per month, revenues of more than $1 million per month, and a pharmacy mindset that closely mirrored the Progressive Care model, we knew we had found a powerful value-add acquisition opportunity. After securing funding for the deal and working through an intense round of due diligence that coincided with the completion of our 2018 audit, we were able to close the acquisition on June 3, 2019.
There were other trials and obstacles during the second half of the year, including a frightening personal health emergency (I'm 100% healthy now). But, in each and every case, we rallied and overcame those challenges with a tenacity that will continue to define the Progressive Care corporate culture in the quarters and years ahead. From the C-suite on down through the front line, every single one of us took up the mantle of "survive and build at all costs".
In particular, I am extremely proud of the way this team performed in terms of the FSRx integration and overall streamlining on the cost side. And, as Q3 2019 drew to a close, we started to see the fruits of our labor.
By October 2019, new contractual relationships with not-for-profit clinics and health care institutions began to come online and drive revenue and profitability growth. The collection of the buying power of all of our locations (North Miami Beach, Davie, Palm Springs, and Orlando) allowed us to negotiate more favorable discounts and purchasing terms. We received our first 2019 performance bonus payout that injected the adrenalin we needed to close out the year stronger than ever. We began seeing payments from PBMs on a timely and less cumbersome basis. We renegotiated the terms of our purchase of FSRx to the benefit of both our shareholders and previous owners. We saw a $10 million revenue quarter, the highest in company history. We filled more than 450,000 prescriptions in 2019, the highest in company history. We had over $32 million in sales, the highest in company history. All of these continue our trend of year-over-year growth for the last 5 years. Our cash flow dramatically improved, as did our profitability, reputation, and ability to execute on new levels.
Additional 2019 Key Highlights
-- Completion of 2018 Audited Financial Statements
-- Secured second acquisition: Family Physicians Rx (aka FPRx, FSRx)
-- Over 450,000 prescriptions filled an increase of 54% (record)
-- Over 45,000 prescriptions filled in a single month (record)
-- Approx. $32 million in net revenues (record, and 56% year-over-year
growth)
-- 5-star rating
-- Top 20% Pharmacy in the nation
-- Highest Humana Scores in Company history (record)
-- Six active Third-Party HealthCare Contracts (record)
-- Increased not-for-profit healthcare claims to over $1 million per month
(record)
-- Processed over $7.5 million in claims on behalf of not-for-profit
entities (record)
-- Reached over 125 employees (record)
-- Licensed in the following states: Colorado, Connecticut, Florida, Georgia,
Illinois, Nevada, New Jersey, New York, Pennsylvania, Texas, Utah,
Arizona, Massachusetts, Minnesota
-- Contributed Articles published in prestigious online magazines: Forbes,
Authority, HuffPost, and Fast Company
Outlook
Looking to the year ahead of us, we have a very ambitious agenda that will test us on many levels.
Upon completion of our 2019 audit, we intend to prepare a new S-1 filing for submission to the SEC. Our many accomplishments in 2019 have made previous drafts out-of-date. After registration with the SEC is complete, we will begin the process of uplisting to a national exchange. We believe that our development as a company now warrants that transition, which will provide us with access to a much larger, more diverse pool of prospective investors, including a much wider institutional investor audience.
We also look forward to further developing our contract services segment, targeting not-for-profit healthcare organizations. The robust growth we have seen in this domain now necessitates the development of a backend administration platform. We believe that our expertise in this area can lead to a significant new revenue stream that will allow us to further capitalize on our sophisticated data analytics capabilities even when we aren't the dispensing pharmacy.
In addition, we established RXMD Therapeutics last year to deliver our own proprietary brands, including our exclusive line of CBD products. We do believe in the therapeutic benefits of CBD and continue to move forward on building our portfolio of products while we create the most efficient pathways for marketability.
We will also focus a great deal of our attention on building out the Hallandale location and the consolidation of the North Miami and Davie pharmacies. We will realize significant savings in 2021 from this consolidation process and we firmly believe the building can support continued expansion in demand for our products and services.
Above and beyond these goals, my vision for the future will require an evolution into a new and more scalable kind of healthcare company. We have been seeking a platform upon which we can build a unique telemedicine product. We are currently in discussions related to achieving this goal and we strongly feel such a product will play a key role for us in the future.
2020 Strategic Goals
-- Achieve 60,000 prescriptions filled in a single month
-- Strive to achieve over $44 million in sales
-- Recognize performance bonuses for all 4 locations
-- Consolidate locations to the Hallandale Beach location
-- Expand market presence to account for all urban centers in Florida
-- Secure additional not-for-profit healthcare contracts and long-term care
facility relationships
-- Achieve full enterprise profitability and earnings growth
-- Launch RXMD Therapeutics exclusive line of CBD products
-- Acquire software platform for the development of proprietary telemedicine
product
-- Develop backend healthcare administration platform for monetization of
expertise in data analytics
-- Become SEC-registered and fully reporting
-- File an application to uplist to a national exchange
Closing Remarks
2019 was indescribably important in defining the future for Progressive Care because we faced tremendous adversity, and not only survived, but thrived, and in the process proved to ourselves that we are capable of responding to a worst-case scenario by turning it into unprecedented success and new avenues of growth and opportunity. That's a priceless lesson for an organization to learn.
We have also been reminded of how grateful we are for our faithful shareholders, who continue to believe in us, and for the strength of our employees, who carried us through 2019. We have employees that have been with us since the beginning, and we acquired a tremendous wealth of new talent through our FSRx transaction, all of whom continue to surprise us and enrich this company with their talents and hard work.
(MORE TO FOLLOW) Dow Jones Newswires
January 23, 2020 08:00 ET (13:00 GMT)
Sugarmade Places on Hold Reverse Split - Plans to Enter Regulated Cannabis Market as Industry Turmoil Creates Opportunities
8:30 AM ET 1/22/20 | GlobeNewswire
Sugarmade Places on Hold Reverse Split - Plans to Enter Regulated Cannabis Market as Industry Turmoil Creates Opportunities
NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Sugarmade, Inc. (OTCQB:SGMD) ("Sugarmade", "SGMD", or the "Company"), today announces the Company has placed a hold on plans to complete a reverse split of its common shares. Pending a vote by its board of directors, management believes temporarily holding the reverse split or canceling the reverse split altogether may be the best future course of action. The Company is also announcing its planned entry into the regulated and licensed portion of the cannabis marketplace, with an emphasis on the California distribution and retail sectors.
Jimmy Chan, CEO of Sugarmade commented, "For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve the right, should circumstances warrant, to reactivate the reverse. We are in the process of modifying our business strategy to better align with where the cannabis marketplace is headed and thus our cancellation of the previously proposed transaction. We see significantly larger opportunities in the California cannabis distribution arena and have entered into advanced talks to make a strategic move into this area."
The cannabis industry in California is rapidly evolving. As recently as only a few months ago, the competitive landscape for legal and licensed cultivators, processors, distributors and retailers was bleak, but the situation has rapidly improved as the crackdown on illegal market participants in California has shown great success. Sugarmade expects these successes to continue. Sugarmade sees a strong opportunity to enter this business arena as the environment changes and as long-time industry participants seek publicly traded partners.
The Company recently announced the rescission of an agreement to acquire a hydroponic equipment supplier. In a filing with the U.S. Securities & Exchange Commission, Sugarmade outlined that approximately 1.2 billion common share equivalents will be returned to the Company's treasury. In addition, the rescission is estimated to save Sugarmade approximately $1 million per month over the next seven months. Sugarmade's board of directors has determined the business combination was no longer viewed as the best shareholder maximization strategy as industry upheaval accelerates. Sugarmade has been presented with numerous other business combination opportunities that its board of directors now believes are superior and are under consideration.
The Company's board of directors believes entry into the regulated portion of the cannabis business sector, which includes hemp and legal THC cannabis cultivation, processing and marketing, is particularly appealing due to the large number of assets within that sub-sector that are currently available for purchase or acquisition. Sugarmade has entered into discussion with several such companies relative to a strategic business combination.
About Sugarmade, Inc.
Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. For more information please reference www.sugarmade.com.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others. such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Corporate Contact:
Jimmy Chan
+1-(888)-982-1628
info@Sugarmade.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
> Dow Jones Newswires
January 22, 2020 08:30 ET (13:30 GMT)
Master Schmucko is the auditor!
Schmucko is the name of the person who sold his position.
He thinks that he tricks people, but he's the one who has been fooled. Since the beginning!
Yes, fins were uploaded last night.
RJD Green Inc. Enters Into Initial Acquisition Discussions With Healthcare IT Services Company
Press Release | 01/22/2020
TULSA, OK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- RJD Green Inc. (OTCPK: RJDG) announced today the Company has entered into initial acquisition and merger discussions with an established Healthcare IT Services firm with services to the Payer market of the Healthcare sector.
The acquisition target offers software and development services to the payer market of the healthcare insurance sector from proprietary software applications. The Company has established long-term relationships within the industry and offers excellent growth potential.
As important, the Company appears to be a synergistic fit with the RJD subsidiary, IOSoft Inc.’s efforts with their Unified Payment Systems.
About IOSoft Inc.
IOSoft provides proprietary software for medical billing, Healthcare claims adjudication, automotive warranty payments, and electronic payments between healthcare Payers and Providers, along with payment software platforms for corporations, government & institutional organizations. Since formation, IOSOFT has been a third-party developer of software and provides IT support for the platforms developed.
The primary focus of IOSoft is in healthcare payment systems where IOSoft can provide unique payment technologies and services or software that can be integrated with legacy or existing systems of healthcare payers and providers such as, major health insurance carriers and third-party administrators. IOSoft provides targeted product offerings for healthcare providers, provider networks, physicians and hospitals; and clearinghouse companies.
About RJD Green, Inc.
The Company operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSoft Inc., a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies; and Silex Holdings Division, which is focused in specialty construction and industrial services. The initial operations, Silex Interiors, fills a market niche between the Home Depots and local contractors. Silex manufactures and installs granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and DIY customer.
Forward-looking Statement:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Company Contact:
RJD Green, Inc.
Ron Brewer, CEO
918.551.7883
ronb@rjdgreen.com
Company Publicist:
Kenneth Quist
918.261.8126
thekwister@aol.com
Master Schmucko doesn't give up:
Wang Binggang: Promoting power exchange model on operating vehicles such as taxis is expected to be profitable
Ji Ming Yang in the Ji Ming YangYesterday
Editor's note: The replacement of fuel vehicles by electric vehicles is the general trend of the times. However, problems such as short cruising range, long charging time, and annual decline in battery energy have always been the bottlenecks that restrict the development of electric vehicles. Especially for the taxis and network-reserved cars with high operating intensity, how to solve the problems of inoperability during charging and the battery decaying year by year. The Zhongyang Mingyang Intelligent Charging Power Station has given the answer, and has been widely recognized by authoritative people and the whole society. .
On January 10-12, the 2020 China Electric Vehicles Hundred People Forum was officially held at the Diaoyutai State Guesthouse. Focusing on the theme of “grasping the situation, focusing on transformation, and leading innovation”, the forum invited relevant government departments and representatives of industry organizations and leading companies in the fields of automotive, energy, transportation, cities, and communications to explore the transformation and innovation of industries, enterprises, and policies. Study and find out the direction and path of industrial adjustment in the next 3-5 years.
Wang Binggang, the leader of the National New Energy Vehicle Innovation Engineering Expert Group , delivered a speech at the New Energy Vehicle Technology Route Forum. He believes that the era of large subsidies has passed, and the new energy vehicle industry must face the market and publish for all aspects of new energy vehicles. Out of view.
The following is the speech record:
good afternoon everyone! Glad to speak here. I will focus on the perspective of the development of pure electric vehicles. Everyone pays attention to plug-in hybrids and fuel cells, but because of time, I only talk about the views on pure electric vehicles today.
Subsidies play a key role in promoting the development of new energy vehicles, which are manifested in many aspects, such as technological progress, enthusiasm of enterprises, and the formation of industrial chains. After the initial formation of the market in recent years, the infrastructure has gradually improved. Because the main aspect of this policy is very good, and it has played a very important role. Of course, the subsidy policy itself has some disadvantages, so the incentive policy that is dominated by the subsidy policy, my point is that it has fulfilled its historical mission well. In the next step, regardless of whether the state continues to maintain a certain level of subsidies, it will maintain its current level. The current amount is very small and will not play a major role. In other words, no matter whether the subsidies will be maintained a little or not after 2021, I think the era of large subsidies has passed. Therefore, I think the new energy vehicle industry must face the market and meet the challenges. This is a major attitude. After 2020, we should further improve the design of the new incentive policy system. In the case of subsidy withdrawal or very small subsidies, how to establish a new policy system to continuously promote the rapid development of new energy vehicles. This is my point about subsidies.
(I) I have a few opinions on the development of electric vehicles that everyone cares about. There are four aspects. After the subsidy is withdrawn, mileage anxiety and other problems should be solved according to the characteristics of different vehicle types. (Such as PPT) This statistic is very meaningful. This is the statistics of the new energy vehicle national data platform on the actual vehicles running on the road. It is not a questionnaire answer in the past, it is a statistic based on actual data. This data statistic has calculated the daily mileage characteristics of various new energy vehicles. I think this number is very important and is the actual starting point for considering the problem in the future. Most of the private passenger cars are concentrated in dozens of kilometers, with an average of only 30 kilometers, and 90% of the daily mileage is 110 kilometers. However, we can also see that private passenger cars still have a certain distribution in the longer driving range. The situation of taxis is significantly different from that of private passenger cars. According to this characteristic, when we were discussing the next technology roadmap a few days ago, the pure electric vehicle drafting group discussed how to outline the technology of electric vehicles in the next step. What about requirements? In the past, we were guided by the mileage, such as how many years did you continue to drive? Do you still say so in the future?
In the end, everyone realized an idea, which is also very interesting. According to the distribution of daily mileage of private cars just mentioned, can we divide pure electric vehicles into two categories:
The first category is called universal. This popular type is based on urban travel, and buying a car is for urban travel. In addition, cities with no purchase restrictions can be used as a second car for families. But now after investigation, the second car often becomes his first car, and the first car is used in terms of use, which is auxiliary in terms of his purchasing psychology, but in fact has become the most important travel tool. Do n’t ask too much for the driving range of this kind of car. For example, is it OK for this kind of car to have a driving range of 300 kilometers? If the charging can be guaranteed, there is no problem driving in the city. Let ’s estimate, according to the technical requirements of such a car, the cost of this car basically has the conditions to compete with fuel cars of the same level, without subsidies. The purchase price of this car is very close to that of ordinary fuel cars, and it uses funds It is very cheap, and the maintenance cost is very cheap. Such cars are fully equipped.
The second type is called high-end type. This kind of car is everyone's pursuit of performance. For example, it must have very good power performance. To maximize the high power of electric vehicles, it requires a relatively long driving range, 400, 500 kilometers or even higher. It is very important that his ability to bear costs is relatively high, and this type of car does not care about subsidies. This type of car represents many new technologies of electric vehicles reflected in the top. Its competition with fuel cars should be based on its better performance. Consumers like it very much. When we consider this issue, the two categories of car sharing will not be entangled. This car is such a feature, that type of car is that feature. Is this the way to think about the next technology roadmap?
(2) Consumers should be assured that electric vehicles should achieve zero fires.This must be a resolute measure to be taken in the next stage. The fire in the previous paragraph was still a little more. Although we have not had a major fire yet, the frequency of fires is relatively high. The reason is that technology is not in place. It is also related to our excessive pursuit of energy density and driving mileage. Some companies are fully charged with battery energy, in fact, some battery cells are often overcharged, which should be the hidden reason for fire. So everyone has to settle down again to do safety technology work well, and leave enough room for energy density or car capacity. In addition, I propose to promote the special charging protection technology of the special call company. We must form a safety guarantee link from battery production to automobile production and finally use. Electric vehicles can completely achieve zero fires and accidents. This must be possible. The safety of electric vehicles is definitely better than that of fuel vehicles. I am sure of this.
( 3) Promoting the power exchange model on operating vehicles such as taxis is expected to be profitable.In the first picture, we can see that the mileage of taxis is very different from that of private individuals. The mileage of taxis each day is relatively large, especially in big cities. It is not enough to turn on the air conditioner. The power exchange mode is very suitable for taxis, and Beijing already has many. I recently went to Guangzhou to inspect the power exchange mode and chat with the driver. They find it economically appropriate. Because they charge per kilometer (0.35 yuan / km), they save about half of their own charging fees. Taxi drivers are very welcome. And he does n’t need to worry about the battery life. It has nothing to do with him. He does n’t have mileage anxiety or battery life anxiety. But can the exchange operator make money? According to the data provided by Guangzhou Olympics Electric Bus Co., he said that if the station ratio can be 70 to 80, one station can share 70-80 cars on average and change the electricity more than 200 times a day. They think that the power station can be profitable I think this can be done.
(IV) Separation of vehicle and electricity is a valuable solution to the anxiety of mileage and battery life of high-end cars.I just talked about popular cars and taxis. Everyone may be concerned about high-end cars like Tesla and Weilai. How to solve the anxiety of mileage? I recently took a look at the "battery bank" concept proposed by Weilai, which means that the battery must be properly separated from the car. It has several plans, such as paying 980 yuan a month, and I sell you a bare car, you can pay the battery every month, and it can be upgraded. You don't have to worry about what to do if my battery is old after a few years of battery improvement. A little money can make you upgrade. There are many ways he can use the residual value of the battery from the car. How the battery of Weilai operates and how it is separated from the vehicle frees consumers from anxiety about the battery, and the manufacturer itself can make a profit. In this regard, I think Weilai Company proposed such a concept, and I think it is very valuable to the highest-end electric vehicles below. The basis for realizing vehicle power separation and increasing the residual value of batteries is a high-quality, reasonably long-life battery. As if this line speaks (such as PPT), the life curve of the blue line is definitely difficult to maintain its residual value, and it may have no value after getting off the car. The battery life curve of the orange line may have re-use value, reducing the cost of the battery from the aspect of increasing the residual value of the battery, and reducing the cost of the entire vehicle.
(5) Electrification of urban public transport must strive to achieve sustainable development.Subsidies for car purchases have a significant impact on the technical route of urban buses. When we first promoted the electrification of urban buses, there were several technical routes, but in the end, long-distance driving mileage prevailed. Because the subsidy is subsidized according to the driving mileage, in fact, it is unreasonable for a bus to pull a lot of batteries, the energy consumption is also very high, and the cost is also very high. It is also problematic to investigate the carbon emissions carefully. There is no way around this, as subsidy policies have guided buses to install more batteries. I think buses may have some more reasonable technical routes in the future. In the past, I had a lot of discussions and researches with Teacher Wang Hewu in this regard. Teacher Wang Hewu also published many articles in this area. I believe that there will definitely be more reasonable technical routes for bus electrification in the future, such as Beijing's Shuangyuan trolley bus. We also recently held a seminar, which is a suitable technical solution for Beijing.
(6) To find applicable market segments, electric trucks are also useful.Everyone thinks that the electrification of trucks is not very pleasant to say, but if you find the entry point and the characteristics, pure electric trucks are also useful. I recently heard a very interesting report: Hongwei New Energy's company developed a 90-ton mine source vehicle, which is characterized by pulling down the mine from the mountain to convert the potential energy of the mountain ore into automatic energy and battery charging. When you go uphill, it is empty, when you go uphill, it is 30 tons, when you go downhill, it is 90 tons. This energy difference is more than enough to help electric cars. Over the next few days, the SOC curve is basically unchanged, and it can basically maintain its own operation, but in fact there is still some maintenance in general, and it still takes a little fuel, but the fuel has been spent very little. This car is initially calculated, and it can be taken over the cost of a fuel car in more than a year. If we have mastered the characteristics and technology of electric vehicles, we cut into some market segments, and there are some scenarios for commercial vehicles that have the prospect of developing electric vehicles.
(7) The construction and operation of infrastructure must be clarified.This is very important. As soon as we talk about infrastructure construction, we will talk about the construction of charging stations, how many charging stations are built, and how many public charging stations are built. This is sometimes not comprehensive enough. As a result of statistics, the current proportion of private car purchase and distribution piles has reached about 70%, that is to say, 70% of privately bought cars have their own piles, so most consumers charge on their own piles, 30% The other half is charged in the company, that is, about 10% of consumers may go to the public charging pile to charge. Of course, public charging piles are still very important. At least about 10% of consumers need to charge. In addition, when cars with private charging piles need subsidies to the outside, they also need to charge at public charging piles. In addition, we must pay more attention to the combination of parking and charging solutions. Various cities combine the two issues of parking difficulty and charging difficulty, and charging at a parking place is the best and most economical solution. This type of solution will be integrated with the power grid in the future. the best. This is true, but it is often put aside when we do it. We are more discussing the issue of public charging piles. Therefore, private popular electric vehicles should be based on parking charging piles, supplemented by public charging piles; high-end electric vehicles can adopt multiple charging methods, such as slow charging, fast charging, battery replacement, battery banking, and other methods to meet Its needs; vehicles in the public domain should be based on the characteristics of each type of vehicle, such as the taxi just mentioned must be replaced with electricity. For example, the bus may be dual-source trackless or fast charging, which should be determined according to specific circumstances. In addition, we should promote the use of renewable energy sources such as photovoltaics, hydropower, and wind energy, promote microgrid technology, and more closely integrate the promotion of power generation and energy reform. We will work in this direction in the future. I reminded that in the construction of infrastructure, we must clarify our thinking and do not lead one-sidedly to one aspect.
(8) Power battery is still the first factor that determines the success or failure of electric vehicles.The development of electric vehicles today is closely related to the progress of batteries. We will have an expectation on the next development of electric vehicles. I think we must actively promote the technical progress of power batteries, including the industrialization of the next generation of new batteries, and we strive to do so, but we must also proceed from reality. At present, I relatively conservatively estimate that I have also discussed with some battery experts. For a considerable period of time in the future, only 300Wh / kg technology may be maintained for a considerable period of time, that is, our battery should still use this as a standpoint in the future. To consider the development of our electric vehicles, we hope that newer batteries will appear. This is our expectation, but it cannot be taken as the view that the entire industry is now based on new batteries in the future. We need to make 300Wh / kg, or even 300Wh / Kg or less, such as lithium iron phosphate, 200Wh / Kg. In my opinion, the most important thing is to have a battery that is in my hands and can be industrialized. The most important are the following: safety first. To reduce costs, we must reduce costs. I think battery factories must work hard. The life is not only the life of the car, but also the life of the step utilization and reuse, and the performance should come after that. From an industrial perspective, we also need to consider (complete) the shortcomings of technology, including the shortcomings of chips, and we must work hard to make the power battery technology more solid. Finally, we need to make a good industrial layout. With the popularity of electric vehicles and the increase in output, what is the reasonable layout of batteries? I think this is worth considering by the entire industry, including battery factories and OEMs. Otherwise, there may be a disconnection at that time.
(9) Local governments should work with car companies to promote the popularization of electric vehicles.I just talked about the policy issues. I think the new energy vehicles and electric vehicles can achieve the current results, which is inseparable from the efforts of the central government and local governments. And I think the local government has done very effective work. I cite the "Liuzhou Model" here. After investigation, there is no restriction on the purchase of traditional cars in Liuzhou, and no restrictions on the number of cars. It is a third-tier city. How can it develop electric cars? Many occasions have been introduced in this regard, everyone has already understood, and now many cities across the country are also studying and understanding these experiences in Liuzhou. In general, the government must start from other aspects to promote the promotion of electric vehicles.
(10) Go abroad and participate in international competition.I think China's electric vehicle industry needs to develop. It is impossible to see only the domestic market. Our electric vehicle penetration is the highest in the world, and many of our electric vehicles are also good. Especially in terms of cost performance, I think we must be internationally competitive. In terms of buses and taxis, I think they may be one of the best in the world. So we should attach importance to the international market in addition to the domestic market. We already have some companies going to foreign markets and have achieved very good results, including big cars and small cars. During this period of time, everyone talked more about Tesla's entry into China, which would have a great impact on China. We can also go abroad. We will also have a great impact on foreign markets. Many companies should consider going abroad as their own strategic arrangement.
Scan with WeChat to
follow the Official Account
There's a possibility of someone else buying this shell (specially because it's now clean) and run another scam.
What's going to happen when Mr Mars aligns with Ms Venus?
Good morning. I think that everything can happen here. This is OTC.
Market Cap Market Ca: 27,251,464
Authorized Shares: 1,000,000,000
Outstanding Shares: 443,113,243
Restricted: 92,501,472
Unrestricted: 350,611,771
Float: 334,506,590
No, this is just consolidation. Filling the gaps.
Have a great weekend you all!
Han Schmucko too!
Too many tricks I meant to say...
Too many trucks in this game. Sell and watch the price rising later.
Have you done any DD or you’re entering in this game based on what you have heard?
Good morning,
I agree that real investors are quietly accumulating $DMAN too. I posted this video recently on twitter and I believe that it's a must see video, because many people do not know the potential of this patented solution GeoEnhanced has. It doesn't work only for oil, but most importantly in my opinion, for water as well. The video comes directly from the company.
Here is my twitter posting:
GeoEnhanced announced their patented technology was valued over $700,000,000.00 or $17.00/share, today the market Cap is $5,133,954 and $0.0119/share.
https://otcmarkets.com/stock/DMAN/security
Watch this must see video:
This would be my very same question.
Too many tricks...
Shorts need to cover. I believe we are going to have a very interesting POWER HOUR!